These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2206997)

  • 1. Effect of recombinant human erythropoietin on anticancer drug-induced anaemia.
    Matsumoto T; Endoh K; Kamisango K; Akamatsu K; Koizumi K; Higuchi M; Imai N; Mitsui H; Kawaguchi T
    Br J Haematol; 1990 Aug; 75(4):463-8. PubMed ID: 2206997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of recombinant human erythropoietin treatment in pre-dialysis patients: results of a multicenter study.
    Albertazzi A; Di Liberato L; Daniele F; Battistel V; Colombi L
    Int J Artif Organs; 1998 Jan; 21(1):12-8. PubMed ID: 9554820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term therapy with recombinant human erythropoietin (rHu-EPO) in progressing multiple myeloma.
    Silvestris F; Romito A; Fanelli P; Vacca A; Dammacco F
    Ann Hematol; 1995 Jun; 70(6):313-8. PubMed ID: 7632811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional erythropoietin-hepcidin axis in recombinant human erythropoietin independent haemodialysis patients.
    Touzot M; Lefebvre T; Roux A; Maheas C; Ridel C; Puy H; Karim Z
    Nephrology (Carlton); 2019 Jul; 24(7):751-757. PubMed ID: 30175513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating anemia associated with chronic renal failure with erythropoiesis stimulators: recombinant human erythropoietin might be the best among the available choices.
    Trkulja V
    Med Hypotheses; 2012 Jan; 78(1):157-61. PubMed ID: 22078846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
    Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Pennington S; Vale L; Wallace S; MacLeod A
    Cochrane Database Syst Rev; 2001; (4):CD003266. PubMed ID: 11687180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of recombinant human erythropoietin on haemolytic anaemia in mice.
    Cynshi O; Shimonaka Y; Higuchi M; Imai N; Suzuki H; Togashi M; Okamoto MT; Hirashima K
    Br J Haematol; 1990 Nov; 76(3):414-9. PubMed ID: 2261351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin deficiency: a complication of cisplatin therapy and its treatment with recombinant human erythropoietin.
    Bray GL; Reaman GH
    Am J Pediatr Hematol Oncol; 1991; 13(4):426-30. PubMed ID: 1785669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.
    Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Vale L; Wallace S; MacLeod A
    Cochrane Database Syst Rev; 2002; (4):CD003895. PubMed ID: 12519614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human erythropoietin treatment for chemotherapy-related anemia in children.
    Varan A; Büyükpamukçu M; Kutluk T; Akyüz C
    Pediatrics; 1999 Feb; 103(2):E16. PubMed ID: 9925862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of recombinant erythropoietin on candidicidal activity of polymorphonuclear leukocytes in hemodialyzed patients].
    Bartůnková J; Sulková S; Cebecauer M
    Cas Lek Cesk; 1995 Dec; 134(23):756-9. PubMed ID: 8599817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Erythropoietin--physiology and therapeutic potentialities].
    Möllmann M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1992 Dec; 27(8):461-8. PubMed ID: 1489869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum erythropoietin levels in ovarian cancer patients receiving chemotherapy.
    Pedain C; Herrero J; Künzel W
    Eur J Obstet Gynecol Reprod Biol; 2001 Oct; 98(2):224-30. PubMed ID: 11574136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human erythropoietin for the treatment of anaemia in patients with chronic idiopathic myelofibrosis.
    Tsiara SN; Chaidos A; Bourantas LK; Kapsali HD; Bourantas KL
    Acta Haematol; 2007; 117(3):156-61. PubMed ID: 17159338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of recombinant human erythropoietin as an antianemic and performance enhancing drug.
    Jelkmann W
    Curr Pharm Biotechnol; 2000 Jul; 1(1):11-31. PubMed ID: 11467358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum erythropoietin and circulating BFU-E in patients with multiple myeloma and anaemia but without renal failure.
    Majumdar G; Westwood NB; Bell-Witter C; Muggleston D; Phillips J; Pearson TC
    Leuk Lymphoma; 1993 Jan; 9(1-2):173-6. PubMed ID: 8477197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin ameliorates anemia of cisplatin induced acute renal failure.
    Baldwin MD; Zhou XJ; Ing TS; Vaziri ND
    ASAIO J; 1998; 44(1):44-7. PubMed ID: 9466500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human erythropoietin is effective in correcting erythropoietin-deficient anaemia after allogeneic bone marrow transplantation.
    Locatelli F; Pedrazzoli P; Barosi G; Zecca M; Porta F; Liberato L; Gambarana D; Nespoli L; Cazzola M
    Br J Haematol; 1992 Apr; 80(4):545-9. PubMed ID: 1581240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human erythropoietin for late-onset anemia after allogeneic bone marrow transplantation.
    Fujimori Y; Kanamaru A; Saheki K; Mori A; Takatsuka H; Wada H; Okada M; Tamura S; Okamoto T; Takemoto Y; Kakishita E; Nagai K
    Int J Hematol; 1998 Feb; 67(2):131-6. PubMed ID: 9631579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum erythropoietin and creatinine concentrations as predictive factors for response to recombinant human erythropoietin treatment in anaemic tumour patients on chemotherapy.
    Fjornes T; Wiedemann GJ; Sack K; Jelkmann W
    Oncol Rep; 1998; 5(1):81-6. PubMed ID: 9458299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.